Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Blocking interferon-gamma might help treat various autoimmune diseases.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The new skin model can predict how chemicals might cause skin allergies.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Blocking certain proteins on immune cells may help treat alopecia areata.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Small molecule IM boosts hair growth by changing stem cell metabolism.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.